Australia, Sept. 18 -- Sandoz AG, owns the trademark (2625799) for 'MACURIMAB' till Feb. 9, 2036.

Status: registered: Registered/protected

Class: 5 [pharmaceutical preparations for human use]

Type of Mark: Word

Date of Acceptance: March 16

Registration Advertised: Sept. 17

For further details contact Duncan Cotterill Lawyers.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2625799.

Disclaimer: Curated by HT Syndication.